VP22 Voyager?

Lisa Kueltzo freckles at eagle.cc.ukans.edu
Fri Feb 19 13:01:45 EST 1999

In the Invitrogen ad, they cite two articles, both from the lad of Peter
O'Hare (MCRI, UK).  In the Nature Biotech. paper (1998.  16:440-443), the
authors demonstrate delivery of p53 by VP22.  In addition, in a recent
paper in Gene Therapy (1999.  6:12-21), they show delivery of HSV
thymidine kinase.  
I hope this helps.


Lisa Kueltzo
Department of Pharmaceutical Chemistry
University of Kansas
2095 Constant Avenue
Lawrence, KS 66047
Phone: (785) 864-3010
Fax: (785) 864-5814

More information about the Methods mailing list